Seeking the optimal aspirin dose in acute coronary syndromes.
Kong
David F
DF
Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA. David.F.Kong@duke.edu
Hasselblad
Vic
V
Kandzari
David E
DE
Newby
L Kristin
LK
Califf
Robert M
RM
D000208:Acute Disease; D001241:Aspirin / Q000008:administration & dosage*; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D023381:Endpoint Determination; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D016239:MEDLINE; D009203:Myocardial Infarction / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D016019:Survival Analysis; D013577:Syndrome; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin